Smartphone heart risk check study
Part of Heart & circulation clinical trials.
This study sees if a smartphone app can safely estimate your heart risk without a doctor visit. It's for people who don't have heart disease or diabetes and can use their own phone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be fluent in German (speaking and reading).
- You need to own a smartphone that can connect to a smartwatch.
- You must not have heart disease, diabetes, chronic kidney disease, or familial high cholesterol.
- You cannot be pregnant or working in the study team's department.
- You must not be in another clinical trial right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows women aged 40–60 to see how smartphones and wearable devices can help monitor health over time. It aims to improve care by using technology that fits easily into daily life.
This study tests if a smartphone app can help people with a chronic heart condition called coronary syndrome. It aims to make care easier and track symptoms at home.
This trial tests whether a smartphone app can accurately measure your blood pressure without a cuff. It may help find people with high blood pressure early using only a phone.
This study tests whether a smartphone app can measure heart rate and heart rate variability using sound recordings, and compares it with standard methods. It might help with future at-home heart monitoring.
This study tests whether a smartphone app can use data from a smartwatch to predict your real-time risk of a heart attack or stroke. If you're at increased risk, this could help you get early warnings and potentially prevent these events.
This study tests if a smartphone camera can measure heart health as accurately as standard medical tests. It might help make heart check-ups easier and more accessible.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.